SRSF1 was a hub gene that was related to prognosis in both Her2 and Luminal A subtypes, and its expression profiles in the two subtypes were similar—it had a higher expression level in the normal tissues than in the tumor tissue (Figure6Q–6R). This evidence concerns the gene ERBB2 and neoplasm.